Navigation Links
NeurogesX to Present at Two November Conferences
Date:10/29/2009

PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza(TM), a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the treatment of neuropathic pain in non-diabetic adults, either alone or in combination with other medicinal products for pain. Qutenza will be marketed in the European Union and certain countries in Eastern Europe, the Middle East and Africa, by Astellas Pharma Europe, Ltd. In the United States, NeurogesX submitted a new drug application (NDA) for PHN to the U.S. Food and Drug Administration (FDA) which was accepted for filing by the FDA in December 2008 and has been given an extended Prescription Drug User Fee Act (PDUFA) date of November 16, 2009.

NeurogesX' second most advanced product candidate, NGX-1998, is a topically applied, liquid formulation containing a high concentration of capsaicin designed to treat pain associated with neuropathic pain conditions. NGX-1998 has completed three Phase 1 studies and NeurogesX is currently planning the design and timing of this program.

NeurogesX' early stage product pipeline includes pre-clinical compounds, which are prodrugs of acetaminophen and various opioids. The company has evaluated these compounds in vitro and in vivo and is currently seeking development partners for these programs.

Safe Harbor Statement

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). NeurogesX disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include, but are not limited to the timing and outcome of regulatory decisions and label approval being sought or that may be obtained with respect to the NDA f
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NeurogesX to Present at UBS Global Life Sciences Conference
2. NeurogesX to Present at Upcoming Fall Conferences
3. NeurogesX Appoints New Board Director and Audit Committee Chairman
4. NeurogesX Reports Second Quarter 2009 Results
5. NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
6. NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
7. NeurogesX Added to Russell 3000 Index
8. NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
9. NeurogesX to Present at Needham Life Sciences Conference
10. NeurogesX Receives European Commission Approval for Qutenza(TM)
11. NeurogesX Reports First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... --  Intrexon Corporation (NYSE: XON ) today ... after the market closes on May 11, 2015.  The ... 5:30 PM ET to discuss the results and provide ... may be accessed by dialing 1-888-346-3959 (Domestic US) and ... Call."  Participants may also access the live webcast through ...
(Date:5/1/2015)... BETHESDA, Md. , May 1, 2015  Northwest ... biotechnology company developing DCVax® personalized immune therapies for solid ... on the $28.5 million second tranche of a $40 ... ("Woodford"). Woodford first invested $25 million in ... 2015, Woodford entered into an agreement with the Company ...
(Date:5/1/2015)... , May 1, 2015 Pfenex ... engaged in the development of biosimilar therapeutics including ... today that its first quarter 2015 financial results ... before the open of market. At 8:30 am Eastern ... to discuss the financial results and provide a ...
(Date:5/1/2015)... LONDON , May 1, 2015 ... following equities: Genetic Technologies Ltd (NASDAQ: GENE ... Thermo Fisher Scientific Inc. (NYSE: TMO ), ... Inc. (NYSE: PKI ). Free research report ... http://get.Investor-Edge.com/pdf/?c=Genetic%20Technologies&d=01-May-2015&s=GENE . On Thursday, April 30, 2015, the ...
Breaking Biology Technology:Intrexon to Announce First Quarter 2015 Financial Results on Monday, May 11, 2015 2NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 2NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 3Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 2Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 3Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 4Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 5
... CHAPEL HILL, N.C., May 7 In ... intense,pricing, political, regulatory and market pressures. These ... business model. Consequently,pharmaceutical and biotechnology companies must ... investment in the commercial enterprise to ensure,health ...
... Scientific,Corporation (NYSE: BSX ) today announced CE ... of pacemakers. ALTRUA is Boston Scientific,s most,advanced pacemaker ... and battery longevity. It is the first Boston ... the heart beats too,slowly -- usually less than ...
... 7 Nikon Instruments, Inc., (http://www.nikoninstruments.com ) ... begun direct,sales and technical support for Nikon,s ... along with Industrial products,including Industrial Microscopes, Measuring ... Rocky Mountain territories. These regions were,previously served ...
Cached Biology Technology:U.S. Pharmaceutical Budget and Staffing: Powerful New Metrics-Based Study 2Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers 2Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers 3Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers 4Nikon Instruments Begins Direct Sales and Technical Support in Southern California and Rocky Mountain Territories 2
(Date:4/1/2015)... 1, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces the second ... is underway to early access pre-order customers. ... at retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, ... was accepted at all outlets and very easy to ...
(Date:3/31/2015)... , March 31, 2015  Elephant Talk Communications ... a global provider of Software Defined Network Architecture (ET ... announced total revenue of approximately $20.4 million for the ... restated $19.5 million for the year ended December 31, ... 2014, the Company had completed its multi-year transition away ...
(Date:3/30/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ... Gesture Recognition Market in Automotive Sector 2014-2018" report ... Global Gesture Recognition market in Automotive Sector to grow ... Gesture recognition is the ability of a ... an individual. Gesture recognition technology can be 2D-based or ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... unlike diamonds, aren,t forever. And when they wear out, ... into amino acids, where they will be recycled into ... Hughes Medical Institute have identified a new way that ... unwanted and potentially toxic proteins, a finding that has ...
... data from two clinical trials presented today at the ... detection of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) ... the world and most often develops as a late ... cause. The overall survival rate of HCC is poor ...
... release is available in French . Ottawa, ... biology research projects will help manage, analyze and interpret vast ... public health and other areas of importance to Canadians and ... needed to advance genomics to its full potential for the ...
Cached Biology News:Scientists discover new way protein degradation is regulated 2Novel screening tests for liver cancer 2Novel screening tests for liver cancer 3New research projects to enhance bioinformatics and computational biology tools and methodologies 2
...
...
Request Info...
LECHNER AND LaVECK MEDIUMfor the clonal growth of normal human bronchial and other epithelial cells. Requires additives. With glutamine.Recommended storage condition:oC to 8oCIntended use(s):research...
Biology Products: